Publications by authors named "C Fesl"

Claim this Profile
P
Palbociclib with adjuvant endocrine therapy in early breast cancer: 5-year follow-up analysis of the global multicenter, open-label, randomized phase III PALLAS trial (ABCSG-42/AFT-05/PrE0109/BIG-14-13).
E L Mayer, D Hlauschek, M Gnant, P J O'Brien, M Bellet-Ezquerra, C Fesl

Ann Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of analysis methodology details on invasive breast cancer-free survival in randomized clinical trials.
D Hlauschek, C Fesl, M Gnant

ESMO Open· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of adding palbociclib on treatment adherence to ongoing adjuvant endocrine treatment in the global randomized PALLAS randomized trial in patients with early breast cancer.
Eileen Shinn, David Zahrieh, Angela DeMichele, Nick Zdenkowski, Julie Lemieux, Christian Fesl

Breast Cancer Res Treat· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the CTS5 in four prospective, multicenter, randomized ABCSG trials.
Kerstin Wimmer, Dominik Hlauschek, Marija Balic, Georg Pfeiler, Richard Greil, Christian Fesl

Breast· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Augmenting Insufficiently Accruing Oncology Clinical Trials Using Generative Models: Validation Study.
Samer El Kababji, Nicholas Mitsakakis, Elizabeth Jonker, Ana-Alicia Beltran-Bless, Gregory Pond, Christian Fesl

J Med Internet Res· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis